182 related articles for article (PubMed ID: 24923638)
1. Better vaccines for healthier life. Part II. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
Pagliusi S; Tippoo P; Sivaramakrishnan V; Nguyen T;
Vaccine; 2014 Nov; 32(48):6330-5. PubMed ID: 24923638
[TBL] [Abstract][Full Text] [Related]
2. Better vaccines for healthier life. Part I. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
Pagliusi S; Rustan R; Huang W; Nguyen T;
Vaccine; 2014 Nov; 32(48):6325-9. PubMed ID: 24923636
[TBL] [Abstract][Full Text] [Related]
3. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
[TBL] [Abstract][Full Text] [Related]
4. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A
Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479
[TBL] [Abstract][Full Text] [Related]
5. The art of partnerships for vaccines.
Pagliusi S; Che Y; Dong S
Vaccine; 2019 Sep; 37(40):5909-5919. PubMed ID: 31447125
[TBL] [Abstract][Full Text] [Related]
6. Vaccines: Shaping global health.
Pagliusi S; Ting CC; Lobos F;
Vaccine; 2017 Mar; 35(12):1579-1585. PubMed ID: 28237501
[TBL] [Abstract][Full Text] [Related]
7. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
Jadhav S; Datla M; Kreeftenberg H; Hendriks J
Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
[TBL] [Abstract][Full Text] [Related]
8. Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.
Pagliusi S; Ting CC; Khomvilai S;
Vaccine; 2016 Jun; 34(31):3562-7. PubMed ID: 26947496
[TBL] [Abstract][Full Text] [Related]
9. Vaccines, inspiring innovation in health.
Pagliusi S; Dennehy M; Kim H;
Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
[TBL] [Abstract][Full Text] [Related]
10. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
11. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
[TBL] [Abstract][Full Text] [Related]
12. Reaching international GMP standards for vaccine production: challenges for developing countries.
Milstien J; Costa A; Jadhav S; Dhere R
Expert Rev Vaccines; 2009 May; 8(5):559-66. PubMed ID: 19397413
[TBL] [Abstract][Full Text] [Related]
13. Casting off vaccine supply charity -- the pace quickens. CVI goal: quality vaccines for all children.
CVI Forum; 1995 Oct; (10):9-13. PubMed ID: 12290725
[TBL] [Abstract][Full Text] [Related]
14. The imperative for stronger vaccine supply and logistics systems.
Zaffran M; Vandelaer J; Kristensen D; Melgaard B; Yadav P; Antwi-Agyei KO; Lasher H
Vaccine; 2013 Apr; 31 Suppl 2():B73-80. PubMed ID: 23598495
[TBL] [Abstract][Full Text] [Related]
15. The global capacity for manufacturing vaccines. Prospects for competition and collaboration among producers in the next decade.
Robbins A; Arita I
Int J Technol Assess Health Care; 1994; 10(1):39-46. PubMed ID: 8157459
[TBL] [Abstract][Full Text] [Related]
16. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
[TBL] [Abstract][Full Text] [Related]
17. Sustaining GAVI-supported vaccine introductions in resource-poor countries.
Zuber PL; El-Ziq I; Kaddar M; Ottosen AE; Rosenbaum K; Shirey M; Kamara L; Duclos P
Vaccine; 2011 Apr; 29(17):3149-54. PubMed ID: 21354249
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
Pagliusi S; Hayman B; Jarrett S
Vaccine; 2021 Apr; 39(18):2479-2488. PubMed ID: 33838948
[TBL] [Abstract][Full Text] [Related]
19. The role of emerging manufacturers in access to innovative vaccines of public health importance.
Milstien JB; Kaddar M
Vaccine; 2010 Feb; 28(9):2115-21. PubMed ID: 20044054
[TBL] [Abstract][Full Text] [Related]
20. Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines.
Keith JA; Agostini Bigger L; Arthur PA; Maes E; Daems R
Vaccine; 2013 Apr; 31 Suppl 2():B184-93. PubMed ID: 23598480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
